financetom
Business
financetom
/
Business
/
Gilead Sciences Insider Sold Shares Worth $283,925, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gilead Sciences Insider Sold Shares Worth $283,925, According to a Recent SEC Filing
Sep 16, 2025 2:54 PM

05:17 PM EDT, 09/16/2025 (MT Newswires) -- Andrew D Dickinson, Chief Financial Officer, on September 15, 2025, sold 2,500 shares in Gilead Sciences ( GILD ) for $283,925. Following the Form 4 filing with the SEC, Dickinson has control over a total of 159,555 common shares of the company, with 159,555 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/882095/000131020425000011/xslF345X05/wk-form4_1758057124.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Silexion Shares Rise Late Following Pretrial Data From Pancreatic Cancer Treatment Showing Efficacy
Silexion Shares Rise Late Following Pretrial Data From Pancreatic Cancer Treatment Showing Efficacy
Jan 15, 2025
05:23 PM EST, 01/15/2025 (MT Newswires) -- Silexion Therapeutics ( SLXN ) was 74% higher in Wednesday's after-hours session, after it disclosed preclinical data demonstrated the synergistic efficacy of its SIL-204 candidate to treat certain form of pancreatic cancer. The data show that SIL-204 worked well in combination with the primary components of two chemotherapies, 5-fluorouracil and irinotecan, in human...
American Lithium's Fiscal Q3 Loss Narrows
American Lithium's Fiscal Q3 Loss Narrows
Jan 15, 2025
05:25 PM EST, 01/15/2025 (MT Newswires) -- American Lithium ( AMLIF ) after close of trade Wednesday its fiscal third-quarter loss narrowed. The lithium explorer said it lost $3.64-million, or $0.02 per share, in the quarter ended Nov.30, compared with a loss of $11.17 million, or $0.05, in the year-prior period. It ended the quarter with $3.49 million of cash...
Cellectis Files for Resale of 44 Million Company Shares by AstraZeneca
Cellectis Files for Resale of 44 Million Company Shares by AstraZeneca
Jan 15, 2025
05:26 PM EST, 01/15/2025 (MT Newswires) -- Cellectis ( CLLS ) filed a registration statement with the US Securities and Exchange Commission on Wednesday for the potential resale of up to 44 million ordinary shares, including in the form of American Depository Shares, by AstraZeneca Holdings from time to time. Cellectis ( CLLS ) said it will not receive any...
Alphabet CEO to join tech leaders at Trump inauguration
Alphabet CEO to join tech leaders at Trump inauguration
Jan 15, 2025
(Reuters) - Alphabet CEO Sundar Pichai is among the Big Tech leaders planning to attend U.S. President-elect Donald Trump's inauguration on Monday, a person familiar with the matter told Reuters on Wednesday. Apple's ( AAPL ) Tim Cook will also be attending the event, Bloomberg News reported earlier in the day. Tech CEOs Elon Musk, Jeff Bezos and Mark Zuckerberg...
Copyright 2023-2026 - www.financetom.com All Rights Reserved